Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Fingolimod (L04Ae01) As Part Of A So-Called Open House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 79937458

  Document Type - Tender Notices

Description - Description Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for drugs with the active ingredient Fingolimod (L04AE01) within the period from May 1st, 2024 to April 30th, 2026 with the possibility of concluding a contract at any time (open-house model ). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (childrens medicines) are excluded., local title Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Fingolimod (L04AE01) im Rahmen eines sogenannten Open-House-Modells.,

Gt Ref Id - 79937458

Deadline - Feb 28, 2026